CMS Open Payments · Program Year 2024
Carbofix Orthopedics Inc
Carbofix Orthopedics Inc reported $49,695.82 across General Payments, Research, and Ownership to 182 physicians and teaching hospitals across 182 transactions.
- $49.7K Below-median payer
- All-tracks total
- 182 Above-median volume
- Transactions
- 182 Above-median reach
- Recipients
- −$29.6K
- General Payments vs PY2023
Carbofix Orthopedics Inc reported $49,695.82 across all CMS Open Payments tracks (General + Research + Ownership) to 182 physicians and teaching hospitals in Program Year 2024 - ranking #1350 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $49,695.82, averaging $273.05 per recipient.
Carbofix Orthopedics Inc's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
24/100
Total payments
F
10/100
Transaction volume
F
11/100
Physician reach
F
11/100
Payment type diversity
D
63/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer carbofix-orthopedics-inc Carbofix Orthopedics Inc
$49.7K · #1350/1,925 · 0.0% industry · PY2024
- TOT $49.7K
- RANK #1350
- SHARE 0.0%
- TXN 182
- RCP 182
- CAT 5
- GEN $49.7K
- ΔGEN −$29.6K
- TOP1 50.5%
- PY 2024
Volume peers
Nearest volume peer: Bolder Surgical, LLC ($49.7K)
Carbofix Orthopedics Inc sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Carbofix Orthopedics Inc's CMS-reported General Payments decreased by $29.6K (−37.4%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: CARBOFIX ORTHOPEDICS INCPY2023: CARBOFIX ORTHOPEDICS INCPY2024: Carbofix Orthopedics Inc. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $79,327.29
- PY2024
- $49,695.82
What the Data Shows for Carbofix Orthopedics Inc
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Carbofix Orthopedics Inc that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
The 5-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Gift" at $25.0K, accounting for 50.3% of this company's General Payments and 1 transactions.
General Payment Breakdown by Type
Across 5 types of general payments, Carbofix Orthopedics Inc's largest category was "Gift" at $25.0K - 50.3% of General Payments.
Carbofix Orthopedics Inc reports 5 general-payment categories - the top three are Gift (50.3%), Food and Beverage (28.8%), and Consulting Fee (12.6%). The remaining 2 categories make up 8.3% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Carbofix Orthopedics Inc divides its payments
General-payment categories, ordered by reported total
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Gift | $25.0K | 1 | 50.3% |
| Food and Beverage | $14.3K | 165 | 28.8% |
| Consulting Fee | $6.3K | 12 | 12.6% |
| Travel and Lodging | $2.9K | 2 | 5.9% |
| Education | $1.2K | 2 | 2.4% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $36,061.21 (72.6%) of $49,695.82 in this company's General Payments records across 119 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Carbofix Orthopedics Inc
The five named recipients with the highest reported General Payments from this company
- 1
Santiago Andres Lozano Calderon
$25,094.33 across 3 reported transactions
- 2
BRUCE JOSEPH ZIRAN Jr
$6,008.17 across 13 reported transactions
- 3
John Alexander Abraham
$1,825.44 across 2 reported transactions
- 4
Howard J Goodman
$1,762.95 across 3 reported transactions
- 5
Daniel Christopher Allison
$1,370.32 across 9 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Carbofix Orthopedics Inc ranks #1350 of 1,925 by total payments (bottom 30% by spend) but is notably more concentrated than that alone would suggest -- #608 of 1,838 by HHI (top 33% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Daiichi Sankyo Europe GmbH : $77.3K total payments, HHI 2769
- Pramand LLC : $22.8K total payments, HHI 2763
- Cleerly, Inc. : $157.5K total payments, HHI 2760
- Biodynamik, Inc : $23.6K total payments, HHI 2759
- Blue Sky Bio, LLC : $314.2K total payments, HHI 2746
- BTG International, Inc. : $670.8K total payments, HHI 2745
- Carbofix Orthopedics Inc (this company) : $49.7K total payments, HHI 2743
- Hyperfine Operations, Inc. : $52.4K total payments, HHI 2743
- 3NT Medical : $11.0K total payments, HHI 2735
- Boehringer Ingelheim Pharma GmbH & Co.KG : $27.7K total payments, HHI 2733
- Carter Bloodcare : $22.6K total payments, HHI 2730
- Kyowa Kirin Services Ltd : $24.7K total payments, HHI 2718
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Carbofix Orthopedics Inc's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Carbofix Orthopedics Inc.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Carbofix Orthopedics Inc.
Showing 6 of 1,924 companies with CMS-reported payment data.
American Medical & Dental Supplies,Inc.
Modulated Imaging, Inc.
Solco Biomedical Co., Ltd.
Foundation Medical, Llc
Naviswiss, Inc.
Put this to use
Carbofix Orthopedics Inc ranks #1350 of 1,925 by all-tracks total payments, led by "Gift".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Gift" spend across every manufacturer, not just Carbofix Orthopedics Inc. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.